1988
DOI: 10.1016/0024-3205(88)90422-5
|View full text |Cite
|
Sign up to set email alerts
|

Hypothalamic site of action for N-methyl-D-aspartate (NMDA) on LH secretion

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

2
44
0

Year Published

1992
1992
2005
2005

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 103 publications
(46 citation statements)
references
References 15 publications
2
44
0
Order By: Relevance
“…These agonists have obvious excitatory effects in vivo ( 1,2,14) and in vitro ( 15,16) whereas an inhibition is obtained by using specific antagonists to NMDA receptors such as AP-5 or MK-801 (17,18). Based on all these data, it was hypothesized that the NMDA receptors involved in GnRH secretion would be increasingly activated from the time of onset of puberty.…”
Section: Introductionmentioning
confidence: 99%
“…These agonists have obvious excitatory effects in vivo ( 1,2,14) and in vitro ( 15,16) whereas an inhibition is obtained by using specific antagonists to NMDA receptors such as AP-5 or MK-801 (17,18). Based on all these data, it was hypothesized that the NMDA receptors involved in GnRH secretion would be increasingly activated from the time of onset of puberty.…”
Section: Introductionmentioning
confidence: 99%
“…Evidence supporting this contention is derived form the following observations: (1) injection of NMDA or kainate into the third ventricle or preoptic area stimulates LH release whereas direct injection of gluta mate into the anterior pituitary has no effect on LH release [59,65]: (2) administration of a GnRH antagonist blocks EAA induced LH release in a variety of species [63, 64. 67], and (3) EAAs stimulate GnRH release from the POA and from ARC-ME fragments in vitro [74,[82][83][84][85][86][87][88].…”
Section: Eaas and Gnrii Secretionmentioning
confidence: 99%
“…Evidence supporting a role for glutamate in the control of GnRH secretion has come from in vivo studies where administration of glutamate, NMDA, kainate and AMPA has been shown to cause a rapid increase in hypothalamic GnRH secretion and/or serum LH levels [1, 2, 3, 4, 5, 6, 7, 8, 9, 10]. The stimulatory effects of glutamate and its agonists on GnRH or LH release can be blocked by using specific antagonists for each glutamate receptor subtype [1, 5, 6, 11, 12, 13].…”
Section: Introductionmentioning
confidence: 99%